• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Avient Corporation

    5/6/25 11:37:55 AM ET
    $AVNT
    Major Chemicals
    Industrials
    Get the next $AVNT alert in real time by email
    avnt-20250331
    0001122976false2025Q112/31http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesavnt:consolidationxbrli:pureiso4217:EURavnt:segmentavnt:company00011229762025-01-012025-03-3100011229762025-03-3100011229762024-01-012024-03-3100011229762024-12-3100011229762023-12-3100011229762024-03-310001122976us-gaap:CommonStockMember2024-12-310001122976us-gaap:TreasuryStockCommonMember2024-12-310001122976us-gaap:AdditionalPaidInCapitalMember2024-12-310001122976us-gaap:RetainedEarningsMember2024-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001122976us-gaap:ParentMember2024-12-310001122976us-gaap:NoncontrollingInterestMember2024-12-310001122976us-gaap:RetainedEarningsMember2025-01-012025-03-310001122976us-gaap:ParentMember2025-01-012025-03-310001122976us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001122976us-gaap:TreasuryStockCommonMember2025-01-012025-03-310001122976us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001122976us-gaap:CommonStockMember2025-03-310001122976us-gaap:TreasuryStockCommonMember2025-03-310001122976us-gaap:AdditionalPaidInCapitalMember2025-03-310001122976us-gaap:RetainedEarningsMember2025-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001122976us-gaap:ParentMember2025-03-310001122976us-gaap:NoncontrollingInterestMember2025-03-310001122976us-gaap:CommonStockMember2023-12-310001122976us-gaap:TreasuryStockCommonMember2023-12-310001122976us-gaap:AdditionalPaidInCapitalMember2023-12-310001122976us-gaap:RetainedEarningsMember2023-12-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001122976us-gaap:ParentMember2023-12-310001122976us-gaap:NoncontrollingInterestMember2023-12-310001122976us-gaap:RetainedEarningsMember2024-01-012024-03-310001122976us-gaap:ParentMember2024-01-012024-03-310001122976us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001122976us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001122976us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001122976us-gaap:CommonStockMember2024-03-310001122976us-gaap:TreasuryStockCommonMember2024-03-310001122976us-gaap:AdditionalPaidInCapitalMember2024-03-310001122976us-gaap:RetainedEarningsMember2024-03-310001122976us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001122976us-gaap:ParentMember2024-03-310001122976us-gaap:NoncontrollingInterestMember2024-03-310001122976avnt:SpecialtyEngineeredMaterialsMember2024-12-310001122976avnt:ColorAdditivesAndInksMember2024-12-310001122976avnt:SpecialtyEngineeredMaterialsMember2025-01-012025-03-310001122976avnt:ColorAdditivesAndInksMember2025-01-012025-03-310001122976avnt:SpecialtyEngineeredMaterialsMember2025-03-310001122976avnt:ColorAdditivesAndInksMember2025-03-310001122976us-gaap:CustomerRelationshipsMember2025-03-310001122976avnt:PatentsTechnologyAndOtherMember2025-03-310001122976us-gaap:TradeNamesMember2025-03-310001122976us-gaap:CustomerRelationshipsMember2024-12-310001122976avnt:PatentsTechnologyAndOtherMember2024-12-310001122976us-gaap:TradeNamesMember2024-12-310001122976avnt:CloudBasedEnterpriseResourcePlanningSystemImpairmentAndOtherRelatedChargesMember2025-01-012025-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-03-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-03-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2023-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-01-012024-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2024-12-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-03-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-01-012025-03-310001122976avnt:WorkforceReductionsMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-03-310001122976avnt:PlantClosingAndOtherMemberavnt:ClariantColorAcquisitionIntegrationRestructuringPlanMember2025-03-310001122976avnt:ConsolidationOfTwoManufacturingSitesMember2025-01-012025-03-310001122976us-gaap:LandAndLandImprovementsMember2025-03-310001122976us-gaap:LandAndLandImprovementsMember2024-12-310001122976us-gaap:BuildingMember2025-03-310001122976us-gaap:BuildingMember2024-12-310001122976us-gaap:MachineryAndEquipmentMember2025-03-310001122976us-gaap:MachineryAndEquipmentMember2024-12-310001122976us-gaap:InternalRevenueServiceIRSMember2024-12-012024-12-310001122976us-gaap:InternalRevenueServiceIRSMember2025-03-042025-03-040001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2025-03-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2025-01-012025-03-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-03-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2025-01-012025-03-310001122976avnt:A6.25SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2025-03-310001122976avnt:A6.25SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2025-01-012025-03-310001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2025-03-310001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2025-01-012025-03-310001122976us-gaap:OtherDebtSecuritiesMember2025-03-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2024-12-310001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:RevolvingCreditFacilityMember2024-01-012024-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-01-012024-12-310001122976avnt:A575SeniorNotesDue2025Memberus-gaap:SeniorNotesMember2024-12-310001122976avnt:A575SeniorNotesDue2025Memberus-gaap:SeniorNotesMember2024-01-012024-12-310001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2024-12-310001122976avnt:A7.125SeniorNotesDue2030Memberus-gaap:SeniorNotesMember2024-01-012024-12-310001122976us-gaap:OtherDebtSecuritiesMember2024-12-310001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMember2024-04-092024-04-090001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-04-092024-04-090001122976avnt:SeniorTermLoanDue2029Memberus-gaap:SecuredDebtMemberus-gaap:BaseRateMember2024-04-092024-04-090001122976avnt:RevolvingCreditFacilityDue2026Memberus-gaap:LineOfCreditMember2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberavnt:November2026Member2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberavnt:August2027Member2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberavnt:January2028Member2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberavnt:January2029Member2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2025-01-012025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMember2024-01-012024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2025-01-012025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:InterestExpenseMember2024-01-012024-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-12-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2025-03-310001122976us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2024-12-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-01-012025-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-01-012025-03-310001122976us-gaap:CorporateNonSegmentMember2025-01-012025-03-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2024-01-012024-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2024-01-012024-03-310001122976us-gaap:CorporateNonSegmentMember2024-01-012024-03-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2025-03-310001122976us-gaap:OperatingSegmentsMemberavnt:ColorAdditivesAndInksMember2024-12-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2025-03-310001122976us-gaap:OperatingSegmentsMemberavnt:SpecialtyEngineeredMaterialsMember2024-12-310001122976us-gaap:CorporateNonSegmentMember2025-03-310001122976us-gaap:CorporateNonSegmentMember2024-12-310001122976avnt:CalvertCityMember2020-02-012020-02-290001122976avnt:CalvertCityMember2025-03-31


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ________________________________________________
    FORM 10-Q
    ________________________________________________
    (Mark One)
    ☒Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the quarterly period ended March 31, 2025
    OR    
     
    ☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    For the transition period from             to             .
    Commission file number 1-16091
     ________________________________________________
    AVIENT CORPORATION
    (Exact name of registrant as specified in its charter)
    ________________________________________________
    Ohio34-1730488
    (State or other jurisdiction(I.R.S. Employer Identification No.)
    of incorporation or organization)
    33587 Walker Road44012
    Avon Lake, Ohio
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (440) 930-1000
    Former name, former address and former fiscal year, if changed since last report: Not Applicable
    _______________________________________________

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Shares, par value $.01 per shareAVNTNew York Stock Exchange
    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒    Yes   ☐ No
    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒    Yes   ☐ No

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☒Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐  Yes   ☒  No

    The number of the registrant’s outstanding common shares, par value $.01 per share, as of March 31, 2025 was 91,532,719.

    AVIENT CORPORATION


    PART I — FINANCIAL INFORMATION
    ITEM 1. FINANCIAL STATEMENTS
    Avient Corporation
    Condensed Consolidated Statements of Income (Unaudited)
    (In millions, except per share data)
    Three Months Ended
    March 31,
     20252024
    Sales$826.6 $829.0 
    Cost of sales563.4 550.8 
    Gross margin263.2 278.2 
    Selling and administrative expense262.5 184.2 
    Operating income0.7 94.0 
    Interest expense, net(26.9)(26.6)
    Other expense, net(0.4)(0.9)
    (Loss) income before income taxes(26.6)66.5 
    Income tax benefit (expense)6.7 (16.8)
    Net (loss) income$(19.9)$49.7 
    Net income attributable to noncontrolling interests(0.3)(0.3)
    Net (loss) income attributable to Avient common shareholders$(20.2)$49.4 
    (Loss) earnings per share attributable to Avient common shareholders - Basic:$(0.22)$0.54 
    (Loss) earnings per share attributable to Avient common shareholders - Diluted:$(0.22)$0.54 
    Weighted-average shares used to compute (loss) earnings per common share:
    Basic91.5 91.2 
    Plus dilutive impact of share-based compensation— 0.8 
    Diluted91.5 92.0 
    Anti-dilutive shares not included in diluted common shares outstanding2.5 1.1 
    Cash dividends declared per share of common stock$0.2700 $0.2575 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    1 AVIENT CORPORATION


    Avient Corporation
    Consolidated Statements of Comprehensive Income (Unaudited)
    (In millions)
     Three Months Ended
    March 31,
     20252024
    Net (loss) income$(19.9)$49.7 
    Other comprehensive income (loss), net of tax:
    Translation adjustments and related hedging instruments29.5 (25.9)
    Total other comprehensive income (loss)29.5 (25.9)
    Total comprehensive income9.6 23.8 
    Comprehensive income attributable to noncontrolling interests(0.3)(0.3)
    Comprehensive income attributable to Avient common shareholders$9.3 $23.5 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    2 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Balance Sheets
    (In millions)
    (Unaudited)
    March 31, 2025
    December 31, 2024
    ASSETS
    Current assets:
    Cash and cash equivalents$456.0 $544.5 
    Accounts receivable, net489.6 399.5 
    Inventories, net372.8 346.8 
    Other current assets111.9 131.3 
    Total current assets1,430.3 1,422.1 
    Property, net951.8 955.3 
    Goodwill1,684.0 1,659.7 
    Intangible assets, net1,464.5 1,450.4 
    Other non-current assets280.6 323.6 
    Total assets$5,811.2 $5,811.1 
    LIABILITIES AND SHAREHOLDERS' EQUITY
    Current liabilities:
    Short-term and current portion of long-term debt$7.8 $7.7 
    Accounts payable422.2 417.4 
    Accrued expenses and other current liabilities268.2 331.0 
    Total current liabilities698.2 756.1 
    Non-current liabilities:
    Long-term debt2,061.3 2,059.3 
    Deferred income taxes268.0 260.4 
    Other non-current liabilities469.3 405.7 
    Total non-current liabilities2,798.6 2,725.4 
    SHAREHOLDERS' EQUITY
    Avient shareholders’ equity2,298.3 2,313.8 
    Noncontrolling interest16.1 15.8 
    Total equity2,314.4 2,329.6 
    Total liabilities and equity$5,811.2 $5,811.1 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    3 AVIENT CORPORATION


    Avient Corporation
    Condensed Consolidated Statements of Cash Flows (Unaudited)
    (In millions)
     Three Months Ended
    March 31,
     20252024
    Operating activities
    Net (loss) income$(19.9)$49.7 
    Adjustments to reconcile net (loss) income to net cash used by operating activities:
    Depreciation and amortization45.3 44.3 
    Cloud-based enterprise resource planning system impairment71.6 — 
    Share-based compensation expense2.4 3.3 
    Changes in assets and liabilities:
    Increase in accounts receivable(83.7)(81.9)
    Increase in inventories(20.3)(12.3)
    (Decrease) increase in accounts payable(1.0)1.7 
    Environmental insurance recovery34.0 — 
    Decrease in incentive accruals(53.1)(16.8)
    Accrued expenses and other assets and liabilities, net(26.4)(30.8)
    Net cash used by operating activities(51.1)(42.8)
    Investing activities
    Capital expenditures(12.5)(24.4)
    Proceeds from plant closures— 2.0 
    Other investing activities— (2.1)
    Net cash used by investing activities(12.5)(24.5)
    Financing activities
    Payments on long-term borrowings— (2.7)
    Cash dividends paid(24.7)(23.5)
    Other financing activities(3.6)(1.9)
    Net cash used by financing activities(28.3)(28.1)
    Effect of exchange rate changes on cash3.4 (6.1)
    Decrease in cash and cash equivalents(88.5)(101.5)
    Cash and cash equivalents at beginning of year544.5 545.8 
    Cash and cash equivalents at end of period$456.0 $444.3 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.

    4 AVIENT CORPORATION


    Avient Corporation
    Consolidated Statements of Shareholders' Equity (Unaudited)
    (In millions)

     Common SharesShareholders’ Equity
    Common
    Shares
    Common
    Shares Held
    in Treasury
    Common
    Shares
    Additional
    Paid-in
    Capital
    Retained EarningsCommon
    Shares Held
    in Treasury
    Accumulated
    Other
    Comprehensive
    (Loss) Income
    Total Avient Shareholders' EquityNon-controlling InterestsTotal
    Equity
    Balance at January 1, 2025
    122.2 (30.8)$1.2 $1,537.5 $1,882.5 $(929.6)$(177.8)$2,313.8 $15.8 $2,329.6 
    Net loss— — — — (20.2)— — (20.2)0.3 (19.9)
    Other comprehensive income— — — — — — 29.5 29.5 — 29.5 
    Cash dividends declared -- $0.2700 per share
    — — — — (24.7)— — (24.7)— (24.7)
    Share-based compensation and exercise of awards— 0.1 — (1.2)— 1.1 — (0.1)— (0.1)
    Balance at March 31, 2025
    122.2 (30.7)$1.2 $1,536.3 $1,837.6 $(928.5)$(148.3)$2,298.3 $16.1 $2,314.4 

     Common SharesShareholders’ Equity
    Common
    Shares
    Common
    Shares  Held
    in Treasury
    Common
    Shares
    Additional
    Paid-in
    Capital
    Retained EarningsCommon
    Shares  Held
    in Treasury
    Accumulated
    Other
    Comprehensive
    (Loss) Income
    Total Avient Shareholders' EquityNon-controlling InterestsTotal
    Equity
    Balance at January 1, 2024
    122.2 (31.0)$1.2 $1,529.7 $1,808.2 $(932.5)$(87.4)$2,319.2 $18.8 $2,338.0 
    Net income— — — — 49.4 — — 49.4 0.3 49.7 
    Other comprehensive loss— — — — — — (25.9)(25.9)— (25.9)
    Noncontrolling interest activity— — — 0.3 — — 0.3 (2.6)(2.3)
    Cash dividends declared -- $0.2575 per share
    — — — — (23.5)— — (23.5)— (23.5)
    Share-based compensation and exercise of awards— 0.1 — 0.9 — 0.9 — 1.8 — 1.8 
    Balance at March 31, 2024
    122.2 (30.9)$1.2 $1,530.9 $1,834.1 $(931.6)$(113.3)$2,321.3 $16.5 $2,337.8 
    See accompanying Notes to the Unaudited Condensed Consolidated Financial Statements.


    5 AVIENT CORPORATION


    Avient Corporation
    Notes to Condensed Consolidated Financial Statements
    (Unaudited)
    Note 1 — BASIS OF PRESENTATION
    The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with Form 10-Q instructions and in the opinion of management contain all adjustments, including those that are normal, recurring and necessary to present fairly the financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in the Annual Report on Form 10-K for the year ended December 31, 2024 of Avient Corporation. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
    Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results that may be attained in subsequent periods or for the year ending December 31, 2025.
    Accounting Standards Adopted
    In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires additional segment disclosures on an annual and interim basis, including significant segment expenses that are regularly provided to the chief operating decision maker. The Company adopted this standard for the year ended December 31, 2024, and interim periods thereafter, and applied retrospective changes to all periods presented in the condensed consolidated financial statements. The adoption of ASU 2023-07 impacted segment disclosures within Note 9, Segment Information.
    Accounting Standards Not Yet Adopted
    ASU 2023-09, Income Taxes, provides guidance requiring disaggregated income tax disclosures on an annual basis, including information on the Company's effective tax rate reconciliation and income taxes paid. This guidance is effective for fiscal years beginning after December 15, 2024, and may be applied prospectively or retrospectively. The Company is currently evaluating the standards impacts on its income taxes disclosures.
    ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures, provides guidance requiring disaggregated disclosure of income statement expenses. This guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. This guidance may be applied prospectively or retrospectively. The Company is currently evaluating the impacts of adopting this standard to its financial statement disclosures.

    Note 2 — GOODWILL AND INTANGIBLE ASSETS
    Goodwill as of March 31, 2025 and December 31, 2024 and changes in the carrying amount of goodwill by segment were as follows:
    (In millions)Specialty Engineered MaterialsColor, Additives and InksTotal
    Balance at December 31, 2024$656.3 $1,003.4 $1,659.7 
    Currency translation14.6 9.7 24.3 
    Balance at March 31, 2025$670.9 $1,013.1 $1,684.0 

    6 AVIENT CORPORATION


    Indefinite and finite-lived intangible assets consisted of the following:

     As of March 31, 2025
    (In millions)Acquisition CostAccumulated AmortizationCurrency TranslationNet
    Customer relationships$726.2 $(243.3)$10.4 $493.3 
    Patents, technology and other847.0 (266.7)8.3 588.6 
    Indefinite-lived trade names362.8 — 19.8 382.6 
    Total$1,936.0 $(510.0)$38.5 $1,464.5 

     As of December 31, 2024
    (In millions)Acquisition CostAccumulated AmortizationCurrency TranslationNet
    Customer relationships$726.2 $(234.9)$(0.4)$490.9 
    Patents, technology and other847.0 (255.8)(6.1)585.1 
    Indefinite-lived trade names362.8 — 11.6 374.4 
    Total$1,936.0 $(490.7)$5.1 $1,450.4 

    Note 3 — RESTRUCTURING, IMPAIRMENT AND OTHER CHARGES
    Cloud-based Enterprise Resource Planning System Impairment and Other Related Charges
    In the first quarter of 2025, the Company completed a review of its cloud-based enterprise resource planning system, S/4HANA, including updated project timelines, cost incurred to date, required internal resources and expected costs to complete the initial site implementations, and the evolution of options that could provide better returns for shareholders. As a result of this review, the Company determined it would cease the ongoing development of S/4HANA.
    As a result of this decision, in the three months ended March 31, 2025, the Company recognized a non-cash, pre-tax impairment charge of $71.6 million associated with capitalized implementation costs. The Company also recognized pre-tax charges of $14.7 million associated with unpaid contractual obligations for hosting fees. Further, the Company recognized charges of $1.6 million associated to severance actions resulting from the decision to cease development of S/4HANA. These charges are included in Selling and administrative expense within the Condensed Consolidated Statements of Income.
    Clariant Color Integration Restructuring Program
    We are engaged in a restructuring program associated with our integration of Clariant Color. These actions are expected to enable us to better serve customers, improve efficiency and deliver cost savings. We expect that the full restructuring plan will be implemented by the end of 2025 and anticipate that we will incur approximately $70.0 million of charges in connection with the restructuring plan. As of March 31, 2025, $62.3 million had been incurred.
    A summary of the Clariant Color integration restructuring is shown below:
    (in millions)Workforce reductionsPlant closing and otherTotal
    Balance at January 1, 2024$30.3 $0.8 $31.1 
    Restructuring charges0.4 1.6 2.0 
    Payments, utilization and translation(23.3)(1.6)(24.9)
    Balance at December 31, 2024$7.4 $0.8 $8.2 
    Payments, utilization and translation(0.7)(0.1)(0.8)
    Balance at March 31, 2025$6.7 $0.7 $7.4 
    Other Restructuring Actions
    In the three months ended March 31, 2025, the Company recognized charges of $7.6 million, primarily associated with the consolidation of two manufacturing sites and a technical center.

    7 AVIENT CORPORATION


    Note 4 — INVENTORIES, NET
    Components of Inventories, net are as follows:
    (In millions)As of March 31, 2025As of December 31, 2024
    Finished products$162.6 $159.2 
    Work in process23.1 21.0 
    Raw materials and supplies187.1 166.6 
    Inventories, net$372.8 $346.8 
    Note 5 — PROPERTY, NET
    Components of Property, net are as follows:
    (In millions)As of March 31, 2025As of December 31, 2024
    Land and land improvements$95.3 $93.9 
    Buildings441.9 438.3 
    Machinery and equipment1,307.5 1,291.6 
    Property, gross1,844.7 1,823.8 
    Less accumulated depreciation(892.9)(868.5)
    Property, net$951.8 $955.3 

    Note 6 — INCOME TAXES
    During the three months ended March 31, 2025, the Company's effective tax rate resulted in a benefit of 25.2% as a result of pre-tax loss in the first quarter of 2025. The pre-tax loss was driven by the Company's cloud-based enterprise resource planning system impairment. The 25.2% income tax benefit was higher than the U.S. federal rate of 21.0% primarily due to the state and local tax benefit of the pre-tax loss.
    During the three months ended March 31, 2024, the Company's effective tax rate of 25.3% was above the U.S. federal rate of 21.0% primarily due to foreign withholding tax, tax on global intangible low-taxed income, non-deductible items, and an increase in foreign valuation allowances. These unfavorable items were partially offset by the U.S. research and development credit.
    In December 2024, Avient received a Notice of Deficiency (Notice) from the U.S. Internal Revenue Service (IRS) proposing an adjustment to the 2019 tax year resulting from a disallowed capital loss. The proposed incremental tax liability associated with the Notice is $23.8 million plus estimated interest of $5.8 million. We contested the Notice by filing a petition in U.S. Tax Court on March 4, 2025. The IRS' answer to Avient's petition included an accuracy-related penalty of $4.8 million. The Company believes that the proposed penalty is also without merit, and we will contest the Notice and the penalty vigorously in Tax Court. However, there can be no assurance this dispute with the IRS will be resolved favorably. As of March 31, 2025, the Company has not recorded any income tax provision related to this matter. An unfavorable resolution in U.S. Tax Court would likely result in cash payment and adversely impact the effective tax rate.


    8 AVIENT CORPORATION


    Note 7 — FINANCING ARRANGEMENTS
    Debt consists of the following instruments:
    As of March 31, 2025 (in millions)Principal AmountUnamortized discount and debt issuance costNet DebtWeighted average interest rate
    Senior secured revolving credit facility due 2026$— $— $— — %
    Senior secured term loan due 2029720.7 14.0 706.7 6.27 %
    7.125% senior notes due 2030
    725.0 7.2 717.8 7.125 %
    6.250% senior notes due 2031
    650.0 8.9 641.1 6.250 %
    Other Debt3.5 — 3.5 
    Total Debt2,099.2 30.1 2,069.1 
    Less short-term and current portion of long-term debt7.8 — 7.8 
    Total long-term debt, net of current portion$2,091.4 $30.1 $2,061.3 
    As of December 31, 2024 (in millions)Principal AmountUnamortized discount and debt issuance costNet DebtWeighted average interest rate
    Senior secured revolving credit facility due 2026$— $— $— — %
    Senior secured term loan due 2029720.7 15.5 705.2 7.30 %
    7.125% senior notes due 2030
    725.0 7.5 717.5 7.125 %
    6.250% senior notes due 2031
    650.0 9.2 640.8 6.250 %
    Other Debt3.5 — 3.5 
    Total Debt2,099.2 32.2 2,067.0 
    Less short-term and current portion of long-term debt7.7 — 7.7 
    Total long-term debt, net of current portion$2,091.5 $32.2 $2,059.3 

    On March 12, 2025, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the Term Loan Amendment). The Term Loan Amendment reduced the interest rate per annum by 25 basis points, which now is either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 1.75%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 0.75%. The maturity date and other terms and conditions are substantially the same as the terms and conditions under the credit agreement immediately prior to the Term Loan Amendment.
    As of March 31, 2025, we had no borrowings outstanding under our senior secured revolving credit facility due 2026 (the Revolving Credit Facility), which had availability of $255.1 million.
    The agreements governing our Revolving Credit Facility and our senior secured term loan, and the indentures and credit agreements governing other debt, contain a number of customary financial and restrictive covenants that, among other things, limit our ability to: sell or otherwise transfer assets, including in a spin-off, incur additional debt or liens, consolidate or merge with any entity or transfer or sell all or substantially all of our assets, pay dividends or make certain other restricted payments, make investments, enter into transactions with affiliates, create dividend or other payment restrictions with respect to subsidiaries, make capital investments and alter the business we conduct. As of March 31, 2025, we were in compliance with all covenants.
    The estimated fair value of Avient’s debt instruments at March 31, 2025 and December 31, 2024 was $2,080.9 million and $2,083.3 million, respectively. The fair value of Avient’s debt instruments was estimated using prevailing market interest rates on debt with similar creditworthiness, terms and maturities and represent Level 2 measurements within the fair value hierarchy.
    Note 8 — DERIVATIVES AND HEDGING
    We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. We formally assess, designate and document, as a hedge of an underlying exposure, the qualifying derivative instrument that will be accounted for as an accounting hedge at inception. Additionally, we assess both at inception and at least quarterly thereafter, whether the financial instruments used in the hedging transaction are effective at offsetting changes in either the fair values or cash flows of the underlying exposures. In accordance with ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12), that ongoing assessment will be done qualitatively for highly effective relationships.

    9 AVIENT CORPORATION


    As a means of mitigating the impact of currency fluctuations on our Euro investments in foreign entities, we have executed cross-currency swaps, in which we pay fixed-rate interest in Euros and receive fixed-rate interest in U.S. dollars related to our future obligations to exchange euros for U.S. dollars. These cross-currency swaps effectively convert a portion of our U.S. dollar denominated fixed-rate debt to Euro denominated fixed-rate debt.
    We currently hold cross-currency swaps with a combined notional amount of €700.0 million maturing in November 2026, €900.0 million maturing in August 2027, €510.5 million maturing in January 2028 and €464.9 million maturing in January 2029. We designated the cross-currency swaps as net investment hedges of our net investment in our European operations under ASU 2017-12 and applied the spot method to these hedges. The changes in fair value of these derivative instruments are recognized within Accumulated Other Comprehensive Income (AOCI) to offset the changes in the values of the net investment being hedged. For the three months ended March 31, 2025, a loss of $44.3 million was recognized within translation adjustments in AOCI, net of tax, compared to a gain of $35.3 million, net of tax, for the three months ended March 31, 2024. Included in Interest expense, net on the Condensed Consolidated Statements of Income is income of $9.0 million for the three months ended March 31, 2025 and 2024, related to interest payments received from counterparties.
    All of our derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. We determine the fair value of our derivatives based on valuation methods, which project future cash flows and discount the future amounts to present value using market based observable inputs, including interest rate curves and foreign currency rates.
    The fair value of derivative financial instruments recognized in the Condensed Consolidated Balance Sheets is as follows:
    (In millions)Balance Sheet Location
    As of
    March 31, 2025
    As of
    December 31, 2024
    Assets
    Cross-currency Swaps (Net Investment Hedge)Other non-current assets$0.4 $6.1 
    Liabilities
    Cross-currency Swaps (Net Investment Hedge)
    Other non-current liabilities$158.8 $104.7 

    Note 9 — SEGMENT INFORMATION
    Avient has two reportable segments: (1) Color, Additives and Inks and (2) Specialty Engineered Materials.
    Operating income is the primary segment performance measure that is reported to our chief operating decision maker (CODM), which is the Company's chief executive officer, for purposes of allocating resources and assessing performance. Operating income at the segment level does not include corporate general and administrative expenses that are not allocated to segments, restructuring charges, share-based compensation costs, environmental remediation costs and associated recoveries, asset impairments, acquisition-related charges, mark-to-market adjustments on pension and other post-retirement obligations, and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.


    10 AVIENT CORPORATION


    Financial information by reportable segment is as follows:
    (In millions)

    Three Months Ended March 31, 2025
    Color, Additives and InksSpecialty Engineered MaterialsCorporateConsolidated
    Total
    Sales$519.7 $308.4 $(1.5)$826.6 
    Cost of sales346.6 210.6 6.2 563.4 
    Selling and administrative expense94.5 50.7 117.3 262.5 
    Operating income$78.6 $47.1 $(125.0)$0.7 
    Interest expense, net(26.9)
    Other expense, net(0.4)
    Loss before income taxes$(26.6)
    Other disclosures:
    Depreciation and amortization$21.7 $21.5 $2.1 $45.3 
    Capital expenditures4.9 6.8 0.8 12.5 


    Three Months Ended March 31, 2024
    Color, Additives and InksSpecialty Engineered MaterialsCorporateConsolidated
    Total
    Sales$515.3 $314.4 $(0.7)$829.0 
    Cost of sales344.1 207.4 (0.7)550.8 
    Selling and administrative expense96.4 53.6 34.2 184.2 
    Operating income$74.8 $53.4 $(34.2)$94.0 
    Interest expense, net(26.6)
    Other expense, net(0.9)
    Income before income taxes$66.5 
    Other disclosures:
    Depreciation and amortization$21.9 $19.6 $2.8 $44.3 
    Capital expenditures3.9 5.3 15.2 24.4 
     Total Assets
    (In millions)As of March 31, 2025As of December 31, 2024
    Color, Additives and Inks$2,627.2 $2,574.2 
    Specialty Engineered Materials2,488.6 2,452.3 
    Corporate695.4 784.6 
    Total assets$5,811.2 $5,811.1 
    Note 10 — COMMITMENTS AND CONTINGENCIES
    We have been notified by federal and state environmental agencies and by private parties that we may be a potentially responsible party (PRP) in connection with the environmental investigation and remediation of certain sites. While government agencies frequently assert that PRPs are jointly and severally liable at these sites, in our experience, the interim and final allocations of liability costs are generally made based on the relative contribution of waste. We may also initiate corrective and preventive environmental projects of our own to support safe and lawful activities at our operations. We believe that compliance with current governmental regulations at all levels will not have a material adverse effect on our financial position, results of operations or cash flows.
    In September 2007, the United States District Court for the Western District of Kentucky (Court) in the case of Westlake Vinyls, Inc. v. Goodrich Corporation, et al., held that Avient must pay the remediation costs at the former Goodrich Corporation Calvert City facility (now largely owned and operated by Westlake Vinyls, Inc. (Westlake Vinyls)), together with certain defense costs of Goodrich Corporation. The rulings also provided that Avient can seek indemnification for contamination attributable to Westlake Vinyls. Following the rulings, the parties to the litigation agreed to settle all claims regarding past environmental costs incurred at the site. The settlement agreement provides a mechanism to pursue allocation of future remediation costs at the Calvert City site to Westlake Vinyls.

    11 AVIENT CORPORATION


    The environmental obligation at the site arose as a result of an agreement between The B.F. Goodrich Company (n/k/a Goodrich Corporation) and our predecessor, The Geon Company, at the time of the initial public offering in 1993. Under the agreement, The Geon Company agreed to indemnify Goodrich Corporation for certain environmental costs at the site. Neither Avient nor The Geon Company ever operated the facility.
    Since 2009, Avient, along with respondents Westlake Vinyls and Goodrich Corporation, has worked with the United States Environmental Protection Agency (USEPA) to address the remedial activities at the site. The USEPA issued its Record of Decision (ROD) in September 2018. In April 2019, the respondents signed an Administrative Settlement Agreement and Order on Consent with the USEPA to conduct the remedial actions at the site. In February 2020, three companies signed the agreed Consent Decree and remedial action Work Plan, which received Federal Court approval in January 2021.
    In 2023, the Company received construction bids based on an interim design for the largest component of remedial action at Calvert City, the construction of a barrier wall around the site. Construction of the initial barrier wall section began in 2024 and was substantially complete as of March 31, 2025. The remaining wall designs and construction are expected to be completed in phases through 2028. As the Company completes further design work and begins construction on the remaining sections of the barrier wall, the Company will update its accrual, which was $136.5 million as of March 31, 2025, for any new information as it becomes available.
    Total environmental accruals of $144.7 million and $146.0 million are reflected within Accrued expenses and other current liabilities and Other non-current liabilities in our Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024, respectively. These undiscounted accruals represent our best estimate of probable future costs that we can reasonably estimate, based upon currently available information and technology and how the remedy will be implemented. It is reasonably possible that we could incur additional costs in excess of the amount accrued, which could be material to our Condensed Consolidated Statements of Income. However, such additional costs cannot be currently estimated as they are dependent upon the results of future testing and findings during the execution of remedial design and remedial action, changes in the Calvert City construction timeline, changes in regulations, technology development, new information, newly discovered conditions and other factors that are not currently known.
    During the three months ended March 31, 2025, Avient recognized costs of $4.9 million primarily associated with the ongoing remedial design and remedial action at Calvert City, compared to costs of $4.0 million recognized during the three months ended March 31, 2024. These costs are recognized in Cost of Sales within the Condensed Consolidated Statements of Income.
    We received $34.0 million of cash associated with Calvert City insurance recoveries in the first quarter of 2025. The associated gain was recognized in the fourth quarter of 2024. Further insurance recoveries, if any, related to remedial activities at the Calvert City site are expected to be immaterial.
    Avient is subject to a broad range of claims, administrative and legal proceedings such as lawsuits that relate to contractual allegations, tax audits, product claims, personal injuries, and employment related matters. Although it is not possible to predict with certainty the outcome or cost of these matters, the Company believes our current reserves are appropriate and these matters will not have a material adverse effect on the condensed consolidated financial statements.

    12 AVIENT CORPORATION


    ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    Our Business
    We are an innovator of materials solutions to help our customers succeed, while enabling a sustainable world. Our products include specialty engineered materials, performance fibers, advanced composites, and color and additive solutions. We are also a highly specialized developer and manufacturer of performance enhancing additives, liquid colorants and silicone colorants. Headquartered in Avon Lake, Ohio, we have manufacturing sites, research and development facilities, design centers and warehouses around the globe. We provide value to our customers through our ability to link our knowledge of polymers and materials science with our manufacturing and supply chain capabilities to provide value-added solutions to designers, assemblers and processors of materials. When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “Avient” and the “Company” mean Avient Corporation and its consolidated subsidiaries.
    Results of Operations — The three months ended March 31, 2025 compared to the three months ended March 31, 2024:
     
    Three Months Ended
    March 31,
    Variances — Favorable (Unfavorable)
    (Dollars in millions, except per share data)20252024Change%
    Change
    Sales$826.6 $829.0 $(2.4)(0.3)%
    Cost of sales563.4 550.8 (12.6)(2.3)%
    Gross margin263.2 278.2 (15.0)(5.4)%
    Selling and administrative expense262.5 184.2 (78.3)(42.5)%
    Operating income0.7 94.0 (93.3)(99.3)%
    Interest expense, net(26.9)(26.6)(0.3)(1.1)%
    Other expense, net(0.4)(0.9)0.5 nm
    (Loss) income before income taxes(26.6)66.5 (93.1)(140.0)%
    Income tax benefit (expense)6.7 (16.8)23.5 nm
    Net (loss) income(19.9)49.7 (69.6)(140.0)%
    Net income attributable to noncontrolling interests(0.3)(0.3)— nm
    Net (loss) income attributable to Avient common shareholders$(20.2)$49.4 $(69.6)(140.9)%
    (Loss) earnings per share attributable to Avient common shareholders - Basic:$(0.22)$0.54 
    (Loss) earnings per share attributable to Avient common shareholders - Diluted:$(0.22)$0.54 
    nm - not meaningful
    Sales
    Sales decreased $2.4 million, or 0.3%, for the three months ended March 31, 2025. Unfavorable foreign currency impacts were 2.1%, while sales, excluding the impacts of foreign exchange, increased 1.8%. The sales increases were primarily within the packaging and healthcare end markets, partially offset by declines in the transportation and defense end markets.
    Gross Margin
    Gross margin as a percentage of sales was 31.8% for the three months ended March 31, 2025 compared to 33.6% for the three months ended March 31, 2024. This decrease was driven primarily by higher restructuring charges of $7.7 million and the mix impacts of lower defense sales.
    Selling and administrative expense
    Selling and administrative expense increased $78.3 million for the three months ended March 31, 2025, primarily driven by an impairment charge of $71.6 million associated with the Company's decision to cease development of the cloud-based enterprise resource planning system, S/4HANA, and charges of $14.7 million associated with unpaid contractual obligations for hosting fees. Offsetting these charges was lower compensation cost for the three months ended March 31, 2025 and unfavorable foreign currency impacts.

    13 AVIENT CORPORATION


    Interest expense, net
    Interest expense, net increased $0.3 million for the three months ended March 31, 2025, primarily due to the write-off of unamortized issuance costs associated with refinancing our senior secured term loan in March 2025, partially offset by the benefit of reduced interest rates resulting from previous refinancing activity.
    Income taxes
    During the three months ended March 31, 2025, the Company’s effective tax rate resulted in a benefit of 25.2% versus an expense of 25.3% for the three months ended March 31, 2024. The income tax benefit was due to a pre-tax loss in the first quarter of 2025, which was driven by the Company's cloud-based enterprise resource planning system impairment. During the three months ended March 31, 2025, the 25.2% income tax benefit was higher than the U.S. federal rate of 21.0% due to the state and local tax benefit of the pre-tax loss. During the three months ended March 31, 2024, the Company's effective tax rate of 25.3% was above the U.S. federal rate of 21.0% primarily due to foreign withholding tax, tax on global intangible low-taxed income, non-deductible items, and an increase in foreign valuation allowances. These unfavorable items were partially offset by the U.S. research and development credit.
    SEGMENT INFORMATION
    Avient has two reportable segments: (1) Color, Additives and Inks; and (2) Specialty Engineered Materials.
    Operating income is the primary segment performance measure that is reported to our chief operating decision maker (CODM), which is the Company's chief executive officer, for purposes of allocating resources and assessing performance. Operating income at the segment level does not include corporate general and administrative expenses that are not allocated to segments, restructuring charges, share-based compensation costs, environmental remediation costs and associated recoveries, asset impairments, acquisition-related charges, mark-to-market adjustments on pension and other post-retirement obligations, and certain other items that are not included in the measure of segment profit or loss that is reported to and reviewed by our CODM. These costs are included in Corporate.
    Sales and Operating Income — The three months ended March 31, 2025 compared to the three months ended March 31, 2024: 
     
    Three Months Ended
    March 31,
    Variances — Favorable
    (Unfavorable)
    (Dollars in millions)20252024Change%  Change
    Sales:
    Color, Additives and Inks$519.7 $515.3 $4.4 0.9 %
    Specialty Engineered Materials
    308.4 314.4 (6.0)(1.9)%
    Corporate(1.5)(0.7)(0.8)114.3%
    Total sales$826.6 $829.0 $(2.4)(0.3)%
    Operating income:
    Color, Additives and Inks$78.6 $74.8 $3.8 5.1 %
    Specialty Engineered Materials
    47.1 53.4 (6.3)(11.8)%
    Corporate(125.0)(34.2)(90.8)(265.5)%
    Total operating income$0.7 $94.0 $(93.3)(99.3)%
    Color, Additives and Inks
    Sales increased $4.4 million, or 0.9%, in the three months ended March 31, 2025 compared to the three months ended March 31, 2024. Unfavorable foreign currency impacts were 2.4%, while sales, excluding the impacts foreign exchange, increased 3.3%. The sales increase was primarily within the packaging and building and construction end markets, partially offset by declines in the transportation end market.
    Operating income increased $3.8 million, or 5.1%, in the three months ended March 31, 2025, primarily driven by increased sales and improved mix, which more than offset unfavorable foreign currency impacts.

    14 AVIENT CORPORATION


    Specialty Engineered Materials
    Sales decreased $6.0 million, or 1.9%, in the three months ended March 31, 2025 compared to the three months ended March 31, 2024. Unfavorable foreign currency impacts were 1.5%, while sales, excluding the impacts of foreign exchange, decreased 0.4%. The sales decrease was primarily within the transportation and defense end markets, which more than offset an increase within the healthcare end market.
    Operating income decreased $6.3 million, or 11.8%, for the three months ended March 31, 2025, primarily driven by the impacts of foreign exchange and lower sales along with unfavorable margin impact associated with lower defense sales.
    Corporate
    Corporate costs increased $90.8 million for the three months ended March 31, 2025, primarily driven by an impairment charge of $71.6 million associated with the Company's decision to cease development of the cloud-based enterprise resource planning system, S/4HANA, charges of $14.7 million associated with unpaid contractual obligations for hosting fees, and increased restructuring costs of $12.1 million. Partially offsetting these charges was lower compensation cost for the three months ended March 31, 2025
    Liquidity and Capital Resources
    Our objective is to finance our business through operating cash flow and an appropriate mix of debt and equity. By laddering the maturity structure, we avoid concentrations of debt maturities, reducing liquidity risk. We may from time to time seek to retire or purchase our outstanding debt with cash and/or exchanges for equity securities, in open market purchases, privately negotiated transactions or otherwise. We may also seek to repurchase our outstanding common shares. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. The amounts involved have been and may continue to be material.
    The following table summarizes our liquidity as of March 31, 2025 and December 31, 2024:
    (In millions)As of March 31, 2025As of December 31, 2024
    Cash and cash equivalents$456.0 $544.5 
    Revolving credit availability255.1 211.4 
    Liquidity$711.1 $755.9 
    As of March 31, 2025, approximately 71% of the Company’s cash and cash equivalents resided outside the United States.
    Expected sources of cash needed to satisfy cash requirements for 2025 include our cash on hand, cash from operations and available liquidity under our revolving credit facility, if necessary. We believe that these sources will also provide sufficient liquidity to satisfy our expected uses of cash for at least the next twelve months and the foreseeable future thereafter. Expected uses of cash for 2025 include interest payments, cash taxes, dividend payments, environmental remediation payments and capital expenditures.
    Cash Flows
    The following describes the significant components of cash flows from operating, investing and financing activities for the three months ended March 31, 2025 and 2024.
    Operating Activities — Net cash used by operating activities increased $8.3 million during the three months ended March 31, 2025 compared to the three months ended March 31, 2024, driven primarily by higher incentive compensation payments and increased working capital, partially offset by insurance proceeds of $34.0 million for previously incurred losses at the Calvert City site.
    Investing Activities — Net cash used by investing activities during the three months ended March 31, 2025 and 2024 of $12.5 million and $24.5 million, respectively, primarily reflects the impact of capital expenditures.
    Financing Activities — Net cash used by financing activities for the three months ended March 31, 2025 and 2024 of $28.3 million and $28.1 million, respectively, primarily reflects the impact of dividends paid.

    15 AVIENT CORPORATION


    Debt
    As of March 31, 2025, aggregate maturities of the principal amount of debt for the current year, next four years and thereafter, are as follows:
    (In millions)
    2025$5.9 
    20267.7 
    20277.6 
    20287.7 
    2029693.8 
    Thereafter1,376.5 
    Aggregate maturities$2,099.2 
    On March 12, 2025, the Company refinanced its senior secured term loan by amending the credit agreement governing such term loan (the Term Loan Amendment). The Term Loan Amendment reduced the interest rate per annum by 25 basis points, which now is either (i) Adjusted Term SOFR (as defined in the Term Loan Amendment) plus 1.75%, or (ii) a Base Rate (as defined in the Term Loan Amendment) plus 0.75%. The maturity date and other terms and conditions are substantially the same as the terms and conditions under the credit agreement immediately prior to the Term Loan Amendment.
    As of March 31, 2025, we were in compliance with all financial and restrictive covenants pertaining to our debt. For additional information regarding our debt, please see Note 7, Financing Arrangements, to the accompanying condensed consolidated financial statements.
    Derivatives and Hedging
    We are exposed to market risks, such as changes in foreign currency exchange rates and interest rates. To manage the volatility related to these exposures we may enter into various derivative transactions. For additional information regarding our derivative instruments, please see Note 8, Derivatives and Hedging, to the accompanying condensed consolidated financial statements.
    Material Cash Requirements
    We have future obligations under various contracts relating to debt and interest payments, operating leases, pension and post-retirement benefit plans, purchase obligations and environmental remediation obligations. During the three months ended March 31, 2025, there were no material changes to these obligations as reported in our Annual Report on Form 10-K for the year ended December 31, 2024.


    16 AVIENT CORPORATION


    CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
    In this Quarterly Report on Form 10-Q, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "will," “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial condition, performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
    •disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
    •the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
    •disruptions or inefficiencies in our supply chain, logistics, or operations;
    •changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change;
    •fluctuations in raw material prices, quality and supply, and in energy prices and supply;
    •demand for our products and services;
    •production outages or material costs associated with scheduled or unscheduled maintenance programs;
    •unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
    •our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
    •information systems failures and cyberattacks;
    •our ability to service our indebtedness and restrictions on our current and future operations due to our indebtedness;
    •amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions;
    •other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts, tariffs and any recessionary conditions; and
    •other factors described in our Annual Report on Form 10-K for the year ended December 31, 2024 under Item 1A, “Risk Factors.”
    We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements. We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.


    17 AVIENT CORPORATION


    ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
    There have been no material changes to exposures to market risk as reported in our Annual Report on Form 10-K for the year ended December 31, 2024.

    ITEM 4. CONTROLS AND PROCEDURES
    Disclosure controls and procedures
    Avient’s management, under the supervision of and with the participation of its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of the design and operation of Avient’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this Quarterly Report. Based upon this evaluation, Avient’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report, its disclosure controls and procedures were effective.
    Changes in internal control over financial reporting
    There were no changes in Avient’s internal control over financial reporting during the quarter ended March 31, 2025 that materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

    PART II — OTHER INFORMATION
    ITEM 1. LEGAL PROCEEDINGS
    Information regarding certain legal proceedings can be found in Note 10, Commitments and Contingencies, to the accompanying condensed consolidated financial statements and is incorporated by reference herein.

    ITEM 1A. RISK FACTORS
    We face a number of risks that could adversely affect our business, results of operations, financial position or cash flows. A discussion of our risk factors can be found in Item 1A, Risk factors, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Except for below, as of March 31, 2025, there have been no material changes to the risk factors that were previously disclosed.
    Changes to foreign trade policy, including new or increased tariffs and changing import/export regulations, could adversely affect our operating results, and the impacts could be material.
    Changes in foreign trade policy, regulatory or economic conditions or in laws governing international trade could materially adversely affect our business. The U.S. has instituted certain changes, and may propose additional changes, in trade policies that include the negotiation or termination of trade agreements, the imposition of higher tariffs on goods exported from the U.S. or imported into the U.S., and other government regulations affecting trade between the U.S. and other countries (such as Canada, Mexico, China, and the European Union) where we conduct our business. Global trade disruption or significant introduction of trade barriers, together with any future downturns in the global economy, could further materially and adversely affect our financial performance.
    As a result of policy changes and government proposals, there may be greater restrictions and economic disincentives on international trade. The new tariffs and other changes in U.S. trade policy have triggered retaliatory actions by affected countries, and foreign governments have instituted or are considering imposing tariffs and trade sanctions. Such changes have the potential to adversely impact the global economy, our industry and the global demand for our products, and as a result, could have a negative impact on our business, financial condition and results of operations.

    18 AVIENT CORPORATION


    ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
    The table below sets forth information regarding the repurchase of shares of our common shares during the period indicated.
    PeriodTotal Number of Shares PurchasedWeighted Average Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program
    Maximum Number of Shares that May Yet be Purchased Under the Program (1)
    January 1 to January 31— $— — 4,957,472 
    February 1 to February 28— — — 4,957,472 
    March 1 to March 31— — — 4,957,472 
    Total— $— — 
    (1) Our Board of Directors approved a common share repurchase program authorizing Avient to purchase its common shares in August 2008, which share repurchase authorization has been subsequently increased from time to time. On December 9, 2020, we announced that we would increase our share buyback by an additional 5.0 million shares. As of March 31, 2025, approximately 5.0 million shares remained available for purchase under these authorizations, which have no expiration. Purchases of common shares may be made by open market purchases or privately negotiated transactions and may be made pursuant to Rule 10b5-1 plans and accelerated share repurchases.
    ITEM 5. OTHER INFORMATION
    Trading Arrangements
    None of the Company's directors or officers (as defined in Rule 16a-1(f) promulgated under the Securities Exchange Act of 1934) adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, during the Company's fiscal quarter ended March 31, 2025.

    19 AVIENT CORPORATION


    ITEM 6. EXHIBITS
    EXHIBIT INDEX
    Exhibit No.Exhibit Description
    3.1
    Amended and Restated Articles of Incorporation of Avient Corporation (as amended through June 30, 2020) (incorporated by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, SEC File No. 1-16091)
    3.2
    Avient Corporation Regulations (amended and restated effective May 11, 2023) (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K, filed May 16, 2023, SEC File No. 1-16091)
    10.1†
    Amendment Agreement No. 10, dated as of March 12, 2025, by and among Avient Corporation, the subsidiaries of Avient Corporation party thereto, the existing lenders under the Term Loan Agreement, Citibank, N.A, as administrative agent, and Truist Bank, as the Amendment No. 10 Additional Term Lender (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, filed March 17, 2025, SEC File No. 1-16091)
    10.2**
    Letter Agreement, dated February 11, 2025, between Joel R. Rathbun and Avient Corporation
    31.1**
    Certification of Ashish K. Khandpur, President, Chief Executive Officer and Board Member, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    31.2**
    Certification of Jamie A. Beggs, Senior Vice President and Chief Financial Officer, pursuant to SEC Rules 13a-14(a) and 15d-14(a), adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
    32.1*
    Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Ashish K. Khandpur, President, Chief Executive Officer and Board Member
    32.2*
    Certification pursuant to 18 U.S.C. § 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by Jamie A. Beggs, Senior Vice President and Chief Financial Officer
    101.INSInline XBRL Instance Document
    101.SCHInline XBRL Taxonomy Extension Schema Document
    101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
    101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
    101.LABInline XBRL Taxonomy Extension Label Linkbase Document
    101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
    104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
    †
    Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request.
    *Furnished herewith.
    **Filed herewith.

    20 AVIENT CORPORATION


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
    May 6, 2025AVIENT CORPORATION
    /s/ Jamie A. Beggs
    Jamie A. Beggs
    Senior Vice President and Chief Financial Officer


    21 AVIENT CORPORATION
    Get the next $AVNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVNT

    DatePrice TargetRatingAnalyst
    3/14/2025$43.00Neutral
    Robert W. Baird
    2/18/2025$56.00Neutral → Buy
    Seaport Research Partners
    10/18/2024Buy → Neutral
    Seaport Research Partners
    8/7/2024$49.00 → $52.00Hold → Buy
    Deutsche Bank
    11/6/2023$46.00 → $37.00Buy → Hold
    Deutsche Bank
    2/16/2023$50.00Perform → Outperform
    Oppenheimer
    10/17/2022$40.00Buy
    Deutsche Bank
    9/28/2022Outperform → Perform
    Oppenheimer
    More analyst ratings

    $AVNT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Robert W. Baird initiated coverage on Avient with a new price target

      Robert W. Baird initiated coverage of Avient with a rating of Neutral and set a new price target of $43.00

      3/14/25 7:30:35 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient upgraded by Seaport Research Partners with a new price target

      Seaport Research Partners upgraded Avient from Neutral to Buy and set a new price target of $56.00

      2/18/25 7:06:32 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient downgraded by Seaport Research Partners

      Seaport Research Partners downgraded Avient from Buy to Neutral

      10/18/24 8:28:20 AM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Avient Corporation

      10-Q - AVIENT CORP (0001122976) (Filer)

      5/6/25 11:37:55 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - AVIENT CORP (0001122976) (Filer)

      5/6/25 6:02:29 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • SEC Form DEFA14A filed by Avient Corporation

      DEFA14A - AVIENT CORP (0001122976) (Filer)

      3/27/25 8:29:41 AM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Avient Announces First Quarter 2025 Results

      First quarter sales of $827 million, reflects 2% organic growth over the prior year quarter, excluding the impact of foreign exchangeFirst quarter GAAP EPS of ($0.22) compared to $0.54 in the prior year quarterFirst quarter adjusted EPS of $0.76, in-line with guidance; growth of 4% over the prior year quarter, excluding an unfavorable impact of $0.03 from foreign exchange2025 full year adjusted EPS guidance range of $2.70 to $2.94, unchanged from prior guidanceCLEVELAND, May 6, 2025 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, today announced its first quarter results for 2025.  The company reported first quarter sales of $826.6 million compared to $82

      5/6/25 6:16:00 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient To Hold First Quarter 2025 Conference Call

      CLEVELAND, April 3, 2025 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, intends to release its first quarter 2025 earnings before the market opens on Tuesday, May 6, 2025.  The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Tuesday, May 6, 2025. The webcast can be viewed live at avient.com/investors, or by clicking on the webcast link here.  Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the dial-in numb

      4/3/25 9:15:00 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient Announces Fourth Quarter and Full Year 2024 Results

      Fourth quarter sales increased 4% to $747 million and full year sales increased 3% to $3,240 millionOrganic sales, which excludes the impact of foreign exchange, grew 5% and 4% in the fourth quarter and full year, respectively, driven by positive growth in all regionsFourth quarter and full year GAAP EPS from continuing operations of $0.52 and $1.84 compared to $0.30 and $0.83 in the prior year Fourth quarter adjusted EPS of $0.49, above mid-point of guidance range of $0.46 to $0.50 and includes a $0.01 unfavorable impact from foreign exchange2024 full year adjusted EPS of $2.66 represents an increase of 13% over the prior year, driven by sales growth and margin expansion in both segments202

      2/13/25 6:15:00 AM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lin Sandra Beach was granted 1,055 shares, increasing direct ownership by 20% to 6,434 units (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      4/2/25 4:14:05 PM ET
      $AVNT
      Major Chemicals
      Industrials
    • Director Wulfsohn William A was granted 1,055 shares (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      4/2/25 3:49:23 PM ET
      $AVNT
      Major Chemicals
      Industrials
    • Director Verduin Patricia was granted 1,055 shares, increasing direct ownership by 5% to 22,679 units (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      4/2/25 3:44:13 PM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    Financials

    Live finance-specific insights

    See more
    • Avient Announces First Quarter 2025 Results

      First quarter sales of $827 million, reflects 2% organic growth over the prior year quarter, excluding the impact of foreign exchangeFirst quarter GAAP EPS of ($0.22) compared to $0.54 in the prior year quarterFirst quarter adjusted EPS of $0.76, in-line with guidance; growth of 4% over the prior year quarter, excluding an unfavorable impact of $0.03 from foreign exchange2025 full year adjusted EPS guidance range of $2.70 to $2.94, unchanged from prior guidanceCLEVELAND, May 6, 2025 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, today announced its first quarter results for 2025.  The company reported first quarter sales of $826.6 million compared to $82

      5/6/25 6:16:00 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient To Hold First Quarter 2025 Conference Call

      CLEVELAND, April 3, 2025 /PRNewswire/ -- Avient Corporation (NYSE:AVNT), an innovator of materials solutions, intends to release its first quarter 2025 earnings before the market opens on Tuesday, May 6, 2025.  The company will then host a webcast with a slide presentation at 8:00 a.m. Eastern Time on Tuesday, May 6, 2025. The webcast can be viewed live at avient.com/investors, or by clicking on the webcast link here.  Conference call participants in the question and answer session should pre-register using the link at avient.com/investors, or here, to receive the dial-in numb

      4/3/25 9:15:00 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • Avient Announces Fourth Quarter and Full Year 2024 Results

      Fourth quarter sales increased 4% to $747 million and full year sales increased 3% to $3,240 millionOrganic sales, which excludes the impact of foreign exchange, grew 5% and 4% in the fourth quarter and full year, respectively, driven by positive growth in all regionsFourth quarter and full year GAAP EPS from continuing operations of $0.52 and $1.84 compared to $0.30 and $0.83 in the prior year Fourth quarter adjusted EPS of $0.49, above mid-point of guidance range of $0.46 to $0.50 and includes a $0.01 unfavorable impact from foreign exchange2024 full year adjusted EPS of $2.66 represents an increase of 13% over the prior year, driven by sales growth and margin expansion in both segments202

      2/13/25 6:15:00 AM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Patterson Robert M bought $839,589 worth of shares (24,304 units at $34.55), increasing direct ownership by 4% to 610,897 units (SEC Form 4)

      4 - AVIENT CORP (0001122976) (Issuer)

      11/20/23 7:22:34 AM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    Leadership Updates

    Live Leadership Updates

    See more
    • Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

      Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

      6/26/24 8:00:00 AM ET
      $A
      $ANIK
      $AVNT
      $MASI
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Medical/Dental Instruments
      Health Care
    • International Paper Announces Changes to Its Board of Directors

       Jamie A. Beggs and Scott A. Tozier to Join as Newest Board Members Ilene S. Gordon to Retire from the Board MEMPHIS, Tenn., May 22, 2024 /PRNewswire/ -- International Paper ("IP") (NYSE:IP) announced that Jamie A. Beggs and Scott A. Tozier have been elected to IP's Board of Directors, effective May 21, 2024. The company also announced that Ilene S. Gordon has retired from the Board citing personal and health reasons, effective May 21, 2024. Ms. Beggs, age 47, currently serves as Senior Vice President and Chief Financial Officer of Avient Corporation (NYSE:AVNT), a premier pr

      5/23/24 10:51:00 AM ET
      $ALB
      $AVNT
      $IP
      Major Chemicals
      Industrials
      Paper
      Basic Materials
    • Avient Appoints Ashish K. Khandpur as Chief Executive Officer Effective December 1, 2023

      Robert M. Patterson to Remain in an Advisory Role Until His Retirement on May 31, 2024 Richard H. Fearon Appointed Non-Executive Chairman of the Board CLEVELAND, Nov. 13, 2023  /PRNewswire/ -- Avient Corporation (NYSE:AVNT), a leading provider of specialized and sustainable material solutions, today announced that its Board of Directors has unanimously voted to elect Dr. Ashish K. Khandpur as President and Chief Executive Officer, effective December 1, 2023.  In connection with this appointment, the Board has elected Richard H. Fearon, Lead Independent Director, as Non-Executive Chairman of the Board, also effective December 1, 2023.

      11/13/23 6:45:00 AM ET
      $AVNT
      Major Chemicals
      Industrials

    $AVNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Avient Corporation (Amendment)

      SC 13G/A - AVIENT CORP (0001122976) (Subject)

      2/13/24 4:58:57 PM ET
      $AVNT
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Avient Corporation (Amendment)

      SC 13G/A - AVIENT CORP (0001122976) (Subject)

      2/9/24 7:50:56 AM ET
      $AVNT
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by Avient Corporation

      SC 13G - AVIENT CORP (0001122976) (Subject)

      3/1/23 1:24:32 PM ET
      $AVNT
      Major Chemicals
      Industrials